Cargando…
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
Sézary syndrome (SS) is a rare, leukemic type of cutaneous T-cell lymphoma (CTCL), for which extracorporeal photopheresis (ECP) is a first-line therapy. Reliable biomarkers to objectively monitor the response to ECP in patients with SS are missing. We examined the quantitative and qualitative impact...
Autores principales: | Iselin, Christoph, Chang, Yun-Tsan, Schlaepfer, Tanja, Fassnacht, Christina, Dimitriou, Florentia, Nägeli, Mirjam, Pascolo, Steve, Hoetzenecker, Wolfram, Bobrowicz, Malgorzata, Guenova, Emmanuella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872039/ https://www.ncbi.nlm.nih.gov/pubmed/33643690 http://dx.doi.org/10.1080/2162402X.2021.1873530 |
Ejemplares similares
-
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
por: Saulite, Ieva, et al.
Publicado: (2020) -
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions
por: Chang, Yun-Tsan, et al.
Publicado: (2021) -
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016) -
Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019) -
What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
por: Akilov, Oleg E.
Publicado: (2023)